Search

The mounting burden of hearing loss worldwide: gearing up global collaboration

As audiology and ENT professionals we all have an inkling about the prevalence and impact of hearing loss, but the true gravity of the situation is even greater than previously thought… It may seem hard to believe, but in the...

The power of the multidisciplinary team in paediatric cochlear implant assessment

Marette, Kate and Justine from the Birmingham Paediatric Centre give a detailed insight into how their team works together to assess children and young people for potential cochlear implantation. Cochlear implants and the specialist MDT The multidisciplinary team in cochlear...

The impact of simulation on ENT training

Surgical training is constantly developing to improve ENT surgeons’ technical and non-technical skills. In this article, Joshua Whittaker, an ENT Registrar and ENT Simulation Fellow at University Hospitals Birmingham, describes the rise of simulation training. Simulation is the recreation of...

Developing an Innovation for ENT – from Idea to Market: how ‘e-i’ did it

Background endoscope-i (e-i) Ltd was incorporated into Companies House on December 3rd, 2012 following eight months of developing our first project, a simple iPhone adapter for endoscopes. Of the three founding shareholders, two are ENT surgeons and one a lecturer...

COVID-19 innovations

The coronavirus pandemic has mobilised medical innovators in an amazing way. We take a look at just a few of the hundreds of innovative products and techniques that have been developed and used in the last few weeks. Some of...

The workplace environment and doctors’ health (ENT)

It is well established that doctors have higher levels of stress, depression and suicide than the general population [1] and most other professional groups (Figure 1 illustrates the factors that can make us ill). In addition they have high levels...

Developing medical devices for children: opportunities and challenges

The development of medical devices for infants and children lags significantly behind the development of devices for adults. While in the United States the Food and Drug Administration (FDA) has set up incentives for developing child age-specific pharmaceuticals, there is...

NHS collaboration and partnership with the pharmaceutical and medical devices industries

Historically the relationship between industry and the NHS has been a cautious one. Both sides have typically worked with only partially disclosed agendas, under a pervading fear of finding themselves on the wrong end of a win-lose negotiation. Things have...

Audiological monitoring in ototoxicity - Are we doing enough?

In this article Ghada Al-Malky explores the dichotomy of life-saving, yet hearing loss-causing medication, and questions whether the hearing healthcare community is doing enough to prevent preventable hearing loss. Ototoxicity is the damage to hearing and / or balance functions...

Physiological mechanisms of hyperacusis: an update

Hyperacusis is a heterogeneous and complex clinical entity, and proposals about physiological mechanisms should reflect these issues. Ben Auerbach helps us navigate through present knowledge in this area, and proposes future directions for research. Hyperacusis is a debilitating hearing disorder...